Former Bristol-Myers exec admits guilt in insider trading case

Robert Ramnarine bought up stock in companies he knew Bristol-Myers was purchasing

A former Bristol-Myers executive is facing hefty fines and decades behind bars for insider trading.

Robert Ramnarine, who worked for the company in various senior roles, admitted that he bought stock in Amylin Pharmaceuticals Inc. because he knew his employer was about to acquire the biotech company for $5.3 billion.


Cathleen Flahardy

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.